Management of immune-related cutaneous adverse events associated with immune checkpoint inhibitors in patients with cancer: an evidence summary

Qi Zhang, Shenting Cheng, Shouqi Wang, Jufen Wu, Hui Cai, Huali Tan, Hui Huang, Zhenzhu Qiu

Open source

DOI
10.1136/bmjopen-2026-122459
Published
2026-09
Container
BMJ Open
Publisher
BMJ
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1136/bmjopen-2026-122459,
  title = {Management of immune-related cutaneous adverse events associated with immune checkpoint inhibitors in patients with cancer: an evidence summary},
  author = {Qi Zhang and Shenting Cheng and Shouqi Wang and Jufen Wu and Hui Cai and Huali Tan and Hui Huang and Zhenzhu Qiu},
  year = {2026},
  journal = {BMJ Open},
  doi = {10.1136/bmjopen-2026-122459},
  url = {https://doi.org/10.1136/bmjopen-2026-122459}
}

RIS

TY  - JOUR
TI  - Management of immune-related cutaneous adverse events associated with immune checkpoint inhibitors in patients with cancer: an evidence summary
AU  - Qi Zhang
AU  - Shenting Cheng
AU  - Shouqi Wang
AU  - Jufen Wu
AU  - Hui Cai
AU  - Huali Tan
AU  - Hui Huang
AU  - Zhenzhu Qiu
PY  - 2026
JO  - BMJ Open
DO  - 10.1136/bmjopen-2026-122459
UR  - https://doi.org/10.1136/bmjopen-2026-122459
ER  - 

APA

Zhang, Q., Cheng, S., Wang, S., Wu, J., Cai, H., Tan, H., Huang, H., & Qiu, Z. (2026). Management of immune-related cutaneous adverse events associated with immune checkpoint inhibitors in patients with cancer: an evidence summary. BMJ Open. https://doi.org/10.1136/bmjopen-2026-122459

Source records